LAUREN CAMPBELL: Open Payments
NPI 1649631797 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 24 payments from 8 companies in 2025. Trend: 2023 $454 · 2024 $198 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| GENZYME CORPORATION | 5 | $139 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| AERIN MEDICAL INC. | 2 | $61 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Optinose US, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Stryker Corporation | 1 | $14 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS, NEFFY, Xhance, Rhapsido, AUDION ET DILATION SYSTEM.
Industry payments across AZ — which companies pay providers there.
